Price P Schaefer 4

4 · Pharmasset Inc · Filed Oct 5, 2011

Form 4

Period: 2011-10-03

DirectorPresident and CEO

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2011-10-03−40,000→ 371,914.66 total
Exercise: $1.50Exp: 2014-08-10→ Common Stock (40,000 underlying)
Exercise/Conversion
Common Stock. $.001 par value per share
2011-10-03$1.50/sh+40,000$60,000→ 806,564 total
Sale
Common Stock, $.001 par value per share
2011-10-03$79.33/sh−40,000$3,173,316→ 766,564 total

Footnotes (6)

[F1]This transaction is the result of standing instructions set forth in a Rule 10b5-1 plan previously established by filer.
[F2]This number reflects a correction of 2 shares from Mr. Price's prior Form 4.
[F3]Represents the weighted average sales price for price increments ranging from $77.71 to $80.56.
[F4]The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
[F5]The options were granted on August 10, 2004. 25% were vested on the one-year anniversary of the grant and 6.25% became vested quarterly thereafter.
[F6]Following this transaction, Mr. Price has 1,246,597.34 options remaining in total from all grants, including the 371,914.66 options reported above.

Documents

1 file